BMP Pharma Trading AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	0	0	0	0	0
Other Revenue	0.03	-	-	-	-
Revenue	0.03	0	0	0	0
Revenue Growth (YoY)	1879.74%	2764.29%	-96.58%	-63.16%	345.20%
Cost of Revenue	0	0	0	0	0
Gross Profit	0.03	0	0	-0	0
Selling, General & Admin	1.14	1.7	1.64	1.12	0.68
Other Operating Expenses	0.17	0.21	0.21	0.06	0.12
Operating Expenses	1.7	1.91	1.85	1.18	0.8
Operating Income	-1.67	-1.91	-1.85	-1.18	-0.8
Interest Expense	-0.01	-0	-0.01	-0.01	-0.01
Interest & Investment Income	0.02	0.02	0.02	0.01	0
Currency Exchange Gain (Loss)	-	0	0	-	-0
Other Non Operating Income (Expenses)	5.47	6.09	5.93	3.4	4.02
Pretax Income	3.81	4.19	4.09	2.22	3.21
Income Tax Expense	1.33	1.31	1.34	0.65	0.59
Net Income	2.48	2.88	2.75	1.57	2.62
Net Income to Common	2.48	2.88	2.75	1.57	2.62
Net Income Growth	-13.87%	4.59%	75.39%	-40.06%	1440.37%
Shares Outstanding (Basic)	-	5	5	5	5
Shares Outstanding (Diluted)	-	5	5	5	5
EPS (Basic)	-	0.55	0.52	0.30	0.50
EPS (Diluted)	-	0.55	0.52	0.30	0.50
EPS Growth	-	4.59%	75.39%	-40.06%	1440.42%
Dividend Per Share	-	0.480	0.500	-	-
Dividend Growth	-	-4.00%	-	-	-
Gross Margin	94.37%	14.28%	39.29%	-46.28%	12.29%
Operating Margin	-5264.38%	-118988.15%	-3301448.21%	-72055.67%	-17878.21%
Profit Margin	7810.73%	179523.63%	4916214.29%	95712.07%	58819.29%
EBITDA	-1.27	-	-1.85	-	-0.8
D&A For EBITDA	0.4	-	0	-	0
EBIT	-1.67	-1.91	-1.85	-1.18	-0.8
Effective Tax Rate	34.86%	31.31%	32.70%	29.30%	18.45%